Pregnancy and the post-partum period are generally regarded as maturational crises equal in importance to those of adolescence and the menopause. Stresses undergone during this period include (a) endocrine changes, (b) activation of unconscious psychological conflicts pertaining to pregnancy and (c) the intrapsychic reorganization of becoming a mother. In light of this, it seems likely that clinically significant interactions of psychosocial and endocrine factors will be found in the aetiology of these disorders. The first month post-partum shows the greatest incidence of overt mental illness (7, 9), and this has led many to relate this disturbance to the termination of placental function and the metabolic and/or endocrine changes accompanying this.
30 male alcoholics, who were anxious by clinical research standards,
received either disulfiram (250 mg) or placebo daily for 1 week. There are claims that
disulfiram has a sedative effect and that this has some useful antianxiety action, but this
had not been tested in a controlled manner. There were no significant differences in the
mean changes between the disulfiram and placebo groups as determined by any of the tests
used. Both the Zung self-rating anxiety scale and the anxiety scale of the profile of mood
states indicated (p < 0.05) that those receiving disulfiram were extreme reactors as compared
to the placebo group; those receiving disulfiram either became more anxious or
experienced the most improvement. The study suggests that disulfiram may selectively
relieve or increase the anxiety level of subgroups of subjects, but does not delineate a
predictor of response.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.